Literature DB >> 15753523

Thalidomide and cancer cachexia: old problem, new hope?

M Stroud1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753523      PMCID: PMC1774467          DOI: 10.1136/gut.2004.053330

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  18 in total

1.  Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients.

Authors:  I Bosaeus; P Daneryd; E Svanberg; K Lundholm
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

Review 2.  Cancer anorexia and cachexia.

Authors:  M J Tisdale
Journal:  Nutrition       Date:  2001-05       Impact factor: 4.008

Review 3.  Cancer cachexia.

Authors:  M D Barber; J A Ross; K C Fearon
Journal:  Surg Oncol       Date:  1999-11       Impact factor: 3.279

Review 4.  Eicosanoid-dependent cancer cachexia and wasting.

Authors:  James A Ross; Kenneth C H Fearon
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-05       Impact factor: 4.294

Review 5.  Dangers of growth hormone therapy in critically ill patients.

Authors:  E Ruokonen; J Takala
Journal:  Ann Med       Date:  2000-07       Impact factor: 4.709

6.  Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor.

Authors:  S J Wigmore; P T Todorov; M D Barber; J A Ross; M J Tisdale; K C Fearon
Journal:  Br J Surg       Date:  2000-01       Impact factor: 6.939

7.  Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.

Authors:  Z H Khan; E J Simpson; A T Cole; M Holt; I MacDonald; D Pye; A Austin; J G Freeman
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

8.  Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.

Authors:  J N Gordon; T M Trebble; R D Ellis; H D Duncan; T Johns; P M Goggin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 9.  Thalidomide: a new anticancer drug?

Authors:  Massimo Fanelli; Roberta Sarmiento; Domenico Gattuso; Guido Carillio; Barbara Capaccetti; Angelo Vacca; Aldo Maria Roccaro; Giampietro Gasparini
Journal:  Expert Opin Investig Drugs       Date:  2003-07       Impact factor: 6.206

10.  A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer.

Authors:  M D Barber; J J Powell; S F Lynch; K C Fearon; J A Ross
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  4 in total

1.  Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines.

Authors:  Aung Naing; Shalini Dalal; Maen Abdelrahim; Jennifer Wheler; Kenneth Hess; Siqing Fu; David S Hong; Filip Janku; Gerald S Falchook; Alyson Ilustre; Fengying Ouyang; Razelle Kurzrock
Journal:  Support Care Cancer       Date:  2015-02-15       Impact factor: 3.603

2.  A Phase II dose titration study of thalidomide for cancer-associated anorexia.

Authors:  Mellar Davis; Wael Lasheen; Declan Walsh; Fade Mahmoud; Leslie Bicanovsky; Ruth Lagman
Journal:  J Pain Symptom Manage       Date:  2011-06-02       Impact factor: 3.612

Review 3.  Thalidomide for managing cancer cachexia.

Authors:  Joanne Reid; Moyra Mills; Marie Cantwell; Chris R Cardwell; Liam J Murray; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 4.  Cardiac cachexia: hic et nunc.

Authors:  Goran Loncar; Jochen Springer; Markus Anker; Wolfram Doehner; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-07-01       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.